Inventor

GIOVANNINI RICCARDO

DE65 patents

⚠️ This page may combine multiple inventors who share the name “GIOVANNINI RICCARDO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GIOVANNINI RICCARDO

BOEHRINGER INGELHEIM INT

Aryl and heteroaryl-fused tetrahydro-1,4-oxazepine amides as somatostatin receptor subtype 4 (SSTR4) agonists

Morpholine and 1,4-oxazepane amides as somatostatin receptor subtype 4 (SSTR4) agonists

Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide

Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide

Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors

Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors

Imidazopyrazine derivatives and the use thereof as medicament

Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide

Cyclic ether derivatives of pyrazolo[1,5-A]pyrimidine-3-carboxyamide

Purine derivatives and the use thereof as medicament

4-pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicament

4-pyridinylmethyl-morpholine derivatives and the use thereof as medicament

4-pyrimidin-5-ylmethyl-morpholine derivatives and the use thereof as medicament

Imidazopyridine derivatives and the use thereof as medicament

Morpholine and 1,4-oxazepane amides as somatostatin receptor subtype 4 (SSTR4) agonists

Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide

CENTREXION THERAPEUTICS CORP

CCR2 receptor antagonists and uses thereof

CCR2 receptor antagonists and uses thereof

Somatostatin receptor subtype 4 (SSTR4) agonists

Somatostatin receptor subtype 4 (SSTR4) agonists

CCR2 receptor antagonists and uses thereof

CCR2 receptor antagonists and uses thereof

Somatostatin receptor subtype 4 (SSTR4) agonists

CCR2 receptor antagonists and uses thereof

EBEL HEINER

Process and intermediates for the production of CCR2 antagonists

CCR2 antagonists

CCR2 antagonists and uses thereof

CCR2 receptor antagonists and uses thereof

Cyclic pyrimidin-4-carboxamides as CCR2 receptor antagonists for treatment of inflammation, asthma and COPD

Selective CCR2 antagonists

GIOVANNINI RICCARDO

1-heterocyclyl-1,5-dihydro-pyrazolo[3,4-D] pyrimidin-4-one derivates and their use as PDE9A modulators

Compounds for the treatment of CNS disorders

Substituted pyrido[3,2-E][1,2,4]-triazolo[4,3-A]pyrazines for the treatment of central nervous system disorders

1-heterocyclyl-1,5-dihydro-pyrazolo[3,4-D] pyrimidin-4-one derivatives and their use as PDE9A modulators

Compounds for the treatment of CNS disorders

GRUNDL MARC

Therapeutic methods employing substituted piperidines which are CCR3 antagonists

Substituted piperidines as CCR3 antagonists

Substituted piperidines as CCR3 antagonists

SMITHKLINE BEECHAM CORP

Treating emesis in a mammal

Chemical compounds

ALVARO GIUSEPPE

Method of treating epilepsy by administering 5-(4{[(2-fluorophenyl)methyl]oxy}phenyl)prolinamide

Methods of treating bipolar disorders

HEINE NIKLAS

6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders

6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders

GLAXO GROUP LTD

Compounds

SMITHKLINE BEECHAN CORP

Chemical compounds

CONVERGENCE PHARMACEUTICALS

Compounds

EICKMEIER CHRISTIAN

1, 5-dihydro-pyrazolo (3, 4-D) pyrimidin-4-one derivatives and their use as PDE9A mudulators for the treatment of CNS disorders

CT XION THERAPEUTICS CORP

Somatostatin receptor subtype 4 (SSTR4) agonists

SMITHKLINE BEECHAM CROP

Chemical compounds